01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

intimal hyperplasia in a rat carotid artery injury model. J
Clin Invest 93, 2351-2356.
Singh D and Rigby PW (1996) The use of histone as a facilitator
to improve the efficiency of retroviral gene transfer. Nucleic
Acids Res 24, 3113-3114.
Smith JD, Wong E, Ginsberg M (1995) Cytochrome P450 1A1
promoter as a genetic switch for the regulatable and
physiological expression of a plasma protein in transgenic
mice. Proc Natl Acad Sci USA 92, 11926-11930.
Smith ML, Chen I-T, Zhan Q, Bae I, Chen C-Y, Gilmer TM,
Kastan MB, O'Connor PM, Fornace Jr AJ (1994) Interaction
of the p53-regulated protein Gadd45 with proliferating cell
nuclear antigen. Science 266: 1376-1380.
Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu
JF, Pastore C, Mahfoudi A, Denefle P, Isner JM, Walsh K
(1997) p21CIP1-mediated inhibition of cell proliferation by
overexpression of the gax homeodomain gene. Genes Dev
11, 1674-1689.
Smith RC, Wills KN, Antelman D, Perlman H, Truong LN,
Krasinski K, Walsh K (1997) Adenoviral constructs
encoding phosphorylation-competent full-length and
truncated forms of the human retinoblastoma protein inhibit
myocyte proliferation and neointima formation. Circulation
96, 1899-1905.
Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S,
Trapnell BC, McClelland A, Kaleko M (1993) Adenovirus
mediated expression of therapeutic plasma levels of human
factor IX in mice. Nature Genet 5, 3970-402.
Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D,
Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR,
Kay MA (1997) Persistent and therapeutic concentrations of
human factor IX in mice after hepatic gene transfer of
recombinant AAV vectors. Nat Genet 16, 270-276.
Somia NV, Zoppe M, Verma IM (1995) Generation of targeted
retroviral vectors by using single-chain variable fragment: an
approach to in vivo gene delivery. Proc Natl Acad Sci USA
92, 7570-7574.
Song S, Wang Y, Bak SY, Lang P, Ullrey D, Neve RL, O'Malley
KL, Geller AI (1997) An HSV-1 vector containing the rat
tyrosine hydroxylase promoter enhances both long-term and
cell type-specific expression in the midbrain. J Neurochem
68, 1792-1803.
Song YK, Liu F, Chu S, Liu D (1997) Characterization of
cationic liposome-mediated gene transfer in vivo by
intravenous administration. Hum Gene Ther 8, 1585-1594.
Sorgi FL, Bhattacharya S, Huang L (1997) Protamine sulfate
enhances lipid-mediated gene transfer. Gene Ther 4, 961-
968.
Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I,
Cline A, Nienhuis AW (1992) Selection of drug-resistant
bone marrow cells in vivo after retroviral transfer of human
MDR1. Science 257, 99-103.
Sorscher EJ, Peng S, Bebok Z, Allan PW, Bennett LLJ, and
Parker WB (1994) Tumor cell bystander killing in colonic
carcinoma utilizing the Escherichia coli DeoD gene to
generate toxic purines. Gene Ther 1, 233-238.
Sowa Y, Shiio Y, Fujita T, Matsumoto T, Okuyama Y, Kato D,
Inoue J, Sawada J, Goto M, Watanabe H, Handa H, Sakai T
Gene Therapy and Molecular Biology Vol 1, page 157
157
(1997) Retinoblastoma binding factor 1 site in the core
promoter region of the human RB gene is activated by
hGABP/E4TF1. Cancer Res 57, 3145-3148.
Spaete, R.R. and Frenkel, N. (1982) The herpes simplex virus
amplicon: a new eucaryotic defective-virus cloningamplifying
vector. Cell 30, 295-304.
Spiegelman BM and Flier JS (1996) Adipogenesis and obesity:
rounding out the big picture. Cell 87, 377-389.
Stahl F (1996) Meiotic recombination in yeast: coronation of the
double-strand-break repair model. Cell 87, 965-968.
Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg
PJ (1997) Generation of angiostatin by reduction and
proteolysis of plasmin. Catalysis by a plasmin reductase
secreted by cultured cells. J Biol Chem 272, 20641-20645.
Stenger JE, Mayr GA, Mann K, Tegtmeyer P (1992) Formation
of stable p53 homotetramers and multiples of tetramers. Mol
Carcinog 5, 102-106.
Stephan D, San H, Yang ZY, Gordon D, Goelz S, Nabel GJ,
Nabel EG (1997) Inhibition of vascular smooth muscle cell
proliferation and intimal hyperplasia by gene transfer of βinterferon.
Mol Med 3, 593-599.
Stinchcomb DT (1995) Constraining the cell cycle: Regulating
cell division and differentiation by gene therapy. Nature
Med 1, 1004-1006.
Stuart E, Haffner R, Oren M, Gruss P (1995) Loss of p53
function through PAX-mediated transcriptional repression.
EMBO J 14, 5638-5645.
Stürzbecher H-W, Donzelmann B, Henning W, Knippschild U,
Buchhop S (1996) p53 is linked directly to homologous
recombination processes via RAD51/RecA protein
interaction. EMBO J 15, 1992-2002.
Su H, Chang JC, Xu SM, and Kan YW (1996) Selective killing
of AFP-positive hepatocellular carcinoma cells by adenoassociated
virus transfer of ther herpes simplex virus
thymidine kinase gene. Hum Gene Ther 7, 463-470.
Suchi M, Dinur T, Desnick RJ, Gatt S, Pereira L, Gilboa E,
Schuchman EG (1992) Retroviral-mediated transfer of the
human acid sphingomyelinase cDNA: Correction of the
metabolic defect in cultured Niemann-Pick disease cells.
Proc Natl Acad Sci USA 89, 3227-3231.
Sugimoto Y, Aksentijevich I, Murray G, Brady RO, Pastan I,
Gottesman MM (1995) Retroviral coexpression of a
multidrug resistance gene (MDR1) and human agalactosidase
A for gene therapy of fabry disease. Hum
Gene Ther 6, 905-915.
Sun TQ, Fernstermacher DA, Vos JM (1994) Human artificial
episomal chromosomes for cloning large DNA fragments in
human cells. Nat Genet 8, 33-41.
Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC,
Davis S, Sato TN, and Yancopoulos GD (1996) Requisite
role of angiopoietin-1, a ligand for the TIE2 receptor, during
embryonic angiogenesis. Cell 87, 1171-1180.
Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K,
Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto
N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K,
Yoshikawa K, and Kamada T (1996) Expression of vascular